Apollo Hospitals Enterprise Limited vs Fredun Pharmaceuticals Ltd

A side-by-side comparison of Apollo Hospitals Enterprise Limited (APOLLOHOSP) and Fredun Pharmaceuticals Ltd (FREDUNPHARMACEUTICALSLTD) — valuation, profitability, growth, and financial health — to help you judge which is the stronger buy today.

The verdict

On the numbers, Apollo Hospitals Enterprise Limited leads APOLLOHOSP vs FREDUNPHARMACEUTICALSLTD on 8 of 14 metrics. See the breakdown below — the right pick still depends on your goals (value vs growth, risk appetite).

  • Valuation22
  • Profitability31
  • Growth02
  • Size & financial health31
ValueReturnsMarginGrowthScaleLow debt

Each axis shows this group's split of that metric, scaled so the leader sits at the edge. Relative to each other, not an absolute score.

Valuation

Even

How expensive each stock is relative to its earnings and book value. Lower usually means cheaper.

58.43
P/E ratio
56.50
13.46
P/B ratio
9.20
0.22%
Dividend yield
0.05%
₹135.04
EPS
₹14.65

Profitability

APOLLOHOSP takes 3/4

How efficiently each company turns capital and sales into profit. Higher is better.

20.48%
Return on equity
15.80%
17.31%
Return on capital
19.00%
14.94%
EBITDA margin
12.00%
7.94%
Net margin
4.63%

Growth

FREDUNPHARMACEUTICALSLTD takes 2/2

Three-year compounded growth. Faster-growing businesses can justify a higher valuation.

14.94%
Revenue CAGR (3Y)
32.46%
33.35%
Profit CAGR (3Y)
43.64%

Size & financial health

APOLLOHOSP takes 3/4

Scale and balance-sheet strength. Bigger revenue/profit and lower debt are generally safer.

₹1.14L Cr
Market cap
₹2,505 Cr
₹25,229 Cr
Revenue
₹454 Cr
₹2,003 Cr
Net profit
₹21 Cr
0.90
Debt / equity
0.80
Apollo Hospitals Enterprise Limited
  • + ["Company has delivered good profit growth of 71.1% CAGR over last 5 years", "Company has delivered good sales growth of 19.0% CAGR over last 5 years"]
  • − ["Stock is trading at 11.98 times its book value"]
Fredun Pharmaceuticals Ltd
  • + ["Company is expected to give good quarter", "Company has delivered good profit growth of 75.2% CAGR over last 5 years", "Debtor days have improved from 87.9 to 53.2 days.", "Company's median sales growth is 28.6% of last 10 years"]
  • − ["Stock is trading at 9.11 times its book value", "Promoter holding has decreased over last 3 years: -5.05%"]
Apollo Hospitals Enterprise Limited full analysis Fredun Pharmaceuticals Ltd full analysis

This comparison is for informational purposes only and is not investment advice. Please consult a SEBI-registered advisor before investing.